A new blood test may be able to detect whether a person has suffered a concussion with 97% accuracy.

This biomarker (called glial fibrillary acidic protein) is released upon injury to the brain and can stay in the bloodstream for up to a week and may possibly eliminate the need for radiation-exposing CT scans.